Skip to main content
Premium Trial:

Request an Annual Quote

Kolli Prasad, Jrg Laukien, Stark Thompson, Elaine Ostrander, and Andrew Carr


Spectrum Pharmaceuticals has appointed Kolli Prasad as director of the company’s research and development department. Prasad comes to the position from Hyderabad, India-based Shantha Biotechnics, where he served for 10 years as head of R&D.

Jörg Laukien has been elected as a class III director of Bruker Biosciences by the company’s board of directors. Laukien will step into the position Jan. 1. He is currently a director or president of numerous Bruker companies in the United States and Europe, and a director of Techneon.

Stark Thompson has been elected non-executive chairman of the board of Gene Logic. Thompson has served as a member of Gene Logic’s Board since February 2002, and served as president and CEO of Life Technologies from 1988–2000.

The National Human Genome Research Institute has named Elaine Ostrander as chief of its Cancer Genetics Branch, one of the seven research branches in the Division of Intramural Research. Ostrander comes to the NHGRI from the Fred Hutchinson Cancer Research Center, in Seattle. She received a BS in 1981 from the University of Washington, and a PhD in 1987 from Oregon Health & Sciences University in Portland.

Andrew Carr, former president of discovery systems for GE Healthcare, is now functioning in an advisory role within the company. Carr was replaced by Joel McComb in August. McComb's previous work experience included a position heading the primary care division of Beckman Coulter.


Filed under

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.